Capstone Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
2,972
-443
| -13% | -$82.2K | 0.03% | 91 |
|
|
2025
Q1 | $716K | Sell |
3,415
-360
| -10% | -$75.4K | 0.04% | 72 |
|
|
2024
Q4 | $671K | Buy |
3,775
+35
| +0.9% | +$6.22K | 0.04% | 77 |
|
|
2024
Q3 | $739K | Buy |
3,740
+482
| +15% | +$95.2K | 0.05% | 75 |
|
|
2024
Q2 | $559K | Sell |
3,258
-433
| -12% | -$74.3K | 0.04% | 81 |
|
|
2024
Q1 | $672K | Sell |
3,691
-86
| -2% | -$15.7K | 0.05% | 71 |
|
|
2023
Q4 | $585K | Sell |
3,777
-190
| -5% | -$29.4K | 0.04% | 74 |
|
|
2023
Q3 | $591K | Sell |
3,967
-1,032
| -21% | -$154K | 0.05% | 68 |
|
|
2023
Q2 | $674K | Buy |
4,999
+207
| +4% | +$27.9K | 0.05% | 63 |
|
|
2023
Q1 | $764K | Sell |
4,792
-226
| -5% | -$36K | 0.06% | 56 |
|
|
2022
Q4 | $811K | Sell |
5,018
-13
| -0.3% | -$2.1K | 0.07% | 54 |
|
|
2022
Q3 | $675K | Buy |
5,031
+226
| +5% | +$30.3K | 0.06% | 55 |
|
|
2022
Q2 | $736K | Buy |
4,805
+1,366
| +40% | +$209K | 0.06% | 61 |
|
|
2022
Q1 | $557K | Buy |
3,439
+998
| +41% | +$162K | 0.04% | 75 |
|
|
2021
Q4 | $330K | Sell |
2,441
-549
| -18% | -$74.2K | 0.02% | 97 |
|
|
2021
Q3 | $322K | Sell |
2,990
-28
| -0.9% | -$3.02K | 0.03% | 90 |
|
|
2021
Q2 | $340K | Buy |
3,018
+560
| +23% | +$63.1K | 0.03% | 91 |
|
|
2021
Q1 | $266K | Buy |
2,458
+28
| +1% | +$3.03K | 0.02% | 91 |
|
|
2020
Q4 | $260K | Sell |
2,430
-717
| -23% | -$76.7K | 0.02% | 90 |
|
|
2020
Q3 | $276K | Hold |
3,147
| – | – | 0.03% | 78 |
|
|
2020
Q2 | $309K | Buy |
+3,147
| New | +$309K | 0.04% | 64 |
|